China, Sept. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on Malignant Risk Prediction of BI-RADS Category 4 Breast Nodules Based on Multi-Omics Data'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132075
Registration Time: 2026/09/09
Type: Observational study
Primary Sponsor: Affiliated Hospital of Chengdu University of Traditional Chinese Medicine
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=288333
Published by HT Digital Content Services with permission from Health Daily Digest....